+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Biochips Market 2019-2027

  • ID: 4772783
  • Report
  • Region: Asia, Asia Pacific
  • 70 pages
  • Triton Market Research
1 of 3

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
Market Outlook

The Asia Pacific biochips market is projected to develop at a CAGR of 19.98% during the forecasted years. The increasing biochips products and applications has proliferated the growth of the biochips market at a remarkable rate. The rapid development in the field of biotechnology and rising demand for precision medicines is also propelling the biochips market in the Asia Pacific region. Australia, Japan, China, South Korea, and India are the key countries driving the biochips market in the region.

The biochips market report consists of three major segments such as type, end users, and substrate material. The end user market is divided into biotechnology and pharmaceutical companies, hospitals and diagnostics centers and academic & research institutes. The increasing government funding and initiatives along with the high demand for high-speed diagnostics and the increasing utilization of personalized medicine are the important factors that are expected to increase the growth of the biochips market in the APAC region.

Competitive Outlook

The dominant competitors in the biochips market are Fluidigm Corporation, Samsung Electronics Inc., Biomerieux Sa., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Merck Gmbh, Agilent Technology Inc., Cepheid Inc., Origene Technologies Inc., Cybrdi Inc., Illumina Inc., Imgenex, Biochain Institute Inc., Gamida For Life Group., and
PerkinElmer Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
1. Biochips Market - Summary


2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.3. Evolution & Transition of Biochips
2.4. Porter's Five Force Analysis
2.5. Market Attractiveness Matrix
2.6. Industry Components
2.7. Regulatory Framework
2.8. Vendor Scorecard
2.9. Key Impact Analysis
2.10. Market Opportunity Insights
2.11. Industry Player Positioning
2.12. Key Market Strategies
2.13. Market Drivers
2.13.1. Growth in Personalized Medicines
2.13.2. Rising Incidences & Treatment of Cancer
2.13.3. Constant Rise in Healthcare Spending Worldwide
2.13.4. Increasing Number of Investments in Biotechnology R&D
2.14. Market Restraints
2.14.1. Inequality in Healthcare Access
2.14.2. Inadequate Technical Awareness Related to Biochips
2.14.3. Complexity of Biological Systems
2.15. Market Opportunities
2.15.1. Developments in Biochips Technology
2.15.2. Asia Pacific to Offer Lucrative Growth Opportunities
2.15.3. Widening Application Areas of Biochips
2.16. Market Challenges
2.16.1. Availability of Substitute Technologies
2.16.2. Unclear Regulatory Guidelines
2.16.3. Cost Constraints

3. Biochips Industry Outlook - By Type
3.1. Dna Chips
3.1.1. Agricultural Biotechnology
3.1.2. Cancer Diagnostics & Treatment
3.1.3. Drug Discovery
3.1.4. Gene Expression
3.1.5. Genomics
3.1.6. Single Nucleotide Polymorphism (Snp) Genotyping
3.1.7. Other Dna Chips
3.2. Lab On a Chip
3.2.1. Clinical Diagnostics
3.2.2. Drug Discovery
3.2.3. Genomics
3.2.4. Point of Care & in Vitro Diagnosis
3.2.5. Proteomics
3.2.6. Other Lab On a Chip
3.3. Protein Chips
3.3.1. Diagnostics
3.3.2. Drug Discovery
3.3.3. Expression Profiling
3.3.4. High Throughput Screening
3.3.5. Proteomics
3.3.6. Other Protein Chips
3.4. Other Chips
3.4.1. Cell Arrays
3.4.2. Tissue Arrays

4. Biochips Industry Outlook - By Substrate Material
4.1. Glass
4.2. Polymers
4.3. Silicon
4.4. Other Substrate Materials

5. Biochips Industry Outlook - By End User
5.1. Biotechnology and Pharmaceutical Companies
5.2. Hospitals and Diagnostics Centers
5.3. Academic and Research Institute

6. Biochips Industry - Asia Pacific
6.1. China
6.2. Japan
6.3. India
6.4. South Korea
6.5. Asean Countries
6.6. Australia and New Zealand
6.7. Rest of Asia Pacific

7. Competitive Landscape
7.1. Agilent Technology Inc.
7.2. Biochain Institute Inc.
7.3. Biomerieux Sa
7.4. Bio-Rad Laboratories Inc.
7.5. Cepheid Inc.
7.6. Cybrdi Inc.
7.7. Fluidigm Corporation
7.8. Gamida For Life Group
7.9. Illumina Inc.
7.10. Imgenex
7.11. Merck Gmbh
7.12. Origene Technologies Inc.
7.13. Perkinelmer Inc.
7.14. Samsung Electronics Inc.
7.15. Thermo Fisher Scientific Inc.

8. Methodology & Scope
8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables
Table 1. Market Attractiveness Matrix For Biochips Market
Table 2. Vendor Scorecard of Biochips Market
Table 3. Regulatory Framework of Biochips Market
Table 4. Key Strategic Developments in Biochips Market
Table 5. Notable Investments Made in Biotechnology Industry in 2017
Table 6. Asia Pacific Biochips Market, Country Outlook, 2019-2027 (In $ Million)
Table 7. Asia Pacific Biochips Market, By Type, 2019-2027 (In $ Million)
Table 8. Asia Pacific Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 9. Asia Pacific Biochips Market, By End User, 2019-2027 (In $ Million)
List of Figures
Figure 1. Asia Pacific Biochips Market, 2019-2027 (In $ Million)
Figure 2. Porter's Five Force Analysis of Biochips Market
Figure 3. Key Impact Analysis
Figure 4. Timeline of Biochips
Figure 5. Market Opportunity Insights, By Type, 2018
Figure 6. Market Opportunity Insights, By End User, 2018
Figure 7. Industry Components of Biochips Market
Figure 8. Key Player Positioning in 2018 (%)
Figure 9. Comparison of Healthcare Spending Per Capita and Out of the Pocket Health Expenditure
Figure 10. Asia Pacific Biochips Market, By Dna Chips, 2019-2027 (In $ Million)
Figure 11. Asia Pacific Dna Chips Market, By Agricultural Biotechnology, 2019-2027 (In $ Million)
Figure 12. Asia Pacific Dna Chips Market, By Cancer Diagnostics & Treatment, 2019-2027 (In $ Million)
Figure 13. Asia Pacific Dna Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 14. Asia Pacific Dna Chips Market, By Gene Expression, 2019-2027 (In $ Million)
Figure 15. Asia Pacific Dna Chips Market, By Genomics, 2019-2027 (In $ Million)
Figure 16. Asia Pacific Dna Chips Market, By Single Nucleotide Polymorphism (Snp) Genotyping, 2019-2027 (In $ Million)
Figure 17. Asia Pacific Dna Chips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 18. Asia Pacific Biochips Market, By Lab On a Chip, 2019-2027 (In $ Million)
Figure 19. Asia Pacific Lab On a Chip Market, By Clinical Diagnostics, 2019-2027 (In $ Million)
Figure 20. Asia Pacific Lab On a Chip Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 21. Asia Pacific Lab On a Chip Market, By Genomics, 2019-2027 (In $ Million)
Figure 22. Asia Pacific Lab On a Chip Market, By Point of Care (Poc) & in Vitro Diagnosis (Ivs), 2019-2027 (In $ Million)
Figure 23. Asia Pacific Lab On a Chip Market, By Proteomics, 2019-2027 (In $ Million)
Figure 24. Asia Pacific Lab On a Chip Market, By Other Lab On a Chip, 2019-2027 (In $ Million)
Figure 25. Asia Pacific Biochips Market, By Protein Chips, 2019-2027 (In $ Million)
Figure 26. Asia Pacific Protein Chips Market, By Diagnostics, 2019-2027 (In $ Million)
Figure 27. Asia Pacific Protein Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 28. Asia Pacific Protein Chips Market, By Expression Profiling, 2019-2027 (In $ Million)
Figure 29. Asia Pacific Protein Chips Market, By High Throughput Screening, 2019-2027 (In $ Million)
Figure 30. Asia Pacific Protein Chips Market, By Proteomics, 2019-2027 (In $ Million)
Figure 31. Asia Pacific Protein Chips Market, By Other Protein Chips, 2019-2027 (In $ Million)
Figure 32. Asia Pacific Biochips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 33. Asia Pacific Other Biochips Market, By Cell Arrays, 2019-2027 (In $ Million)
Figure 34. Asia Pacific Other Biochips Market, By Tissue Arrays, 2019-2027 (In $ Million)
Figure 35. Asia Pacific Biochips Market, By Glass, 2019-2027 (In $ Millions)
Figure 36. Asia Pacific Biochips Market, By Polymers, 2019-2027 (In $ Millions)
Figure 37. Asia Pacific Biochips Market, By Silicon, 2019-2027 (In $ Millions)
Figure 38. Asia Pacific Biochips Market, By Other Substrate Materials, 2019-2027 (In $ Millions)
Figure 39. Asia Pacific Biochips Market, By Biotechnology and Pharmaceutical Companies, 2019-2027 (In $ Millions)
Figure 40. Asia Pacific Biochips Market, By Hospitals and Diagnostics Centers, 2019-2027 (In $ Millions)
Figure 41. Asia Pacific Biochips Market, By Academic and Research Institute, 2019-2027 (In $ Millions)
Figure 42. Asia Pacific Biochips Market, Regional Outlook, 2018 & 2027 (In %)
Figure 43. China Biochips Market, 2019-2027 (In $ Million)
Figure 44. Japan Biochips Market, 2019-2027 (In $ Million)
Figure 45. India Biochips Market, 2019-2027 (In $ Million)
Figure 46. South Korea Biochips Market, 2019-2027 (In $ Million)
Figure 47. Asean Countries Biochips Market, 2019-2027 (In $ Million)
Figure 48. Australia & New Zealand Biochips Market, 2019-2027 (In $ Million)
Figure 49. Rest of Asia-Pacific Biochips Market, 2019-2027 (In $ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AGilent Technology Inc.
  • Biochain Institute Inc.
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Cybrdi Inc.
  • Fluidigm Corporation
  • Gamida For Life Group
  • Illumina Inc.
  • Imgenex
  • Merck GmbH
  • Origene Technologies Inc.
  • Perkinelmer Inc.
  • Samsung Electronics Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4772783
Adroll
adroll